| pubmed-article:2842553 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2842553 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:2842553 | lifeskim:mentions | umls-concept:C0003451 | lld:lifeskim |
| pubmed-article:2842553 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:2842553 | lifeskim:mentions | umls-concept:C0024432 | lld:lifeskim |
| pubmed-article:2842553 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:2842553 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:2842553 | lifeskim:mentions | umls-concept:C0392760 | lld:lifeskim |
| pubmed-article:2842553 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2842553 | pubmed:dateCreated | 1988-10-6 | lld:pubmed |
| pubmed-article:2842553 | pubmed:abstractText | The intrinsic antiviral activity of macrophages has been studied in healthy donors and in patients affected by breast cancer and melanoma. In vitro differentiated macrophages from blood-derived monocytes were infected with measles virus, herpes simplex virus type 2 and adenovirus 17. The challenge was carried out with different multiplicities of infection and the synthesis of virus was tested by evaluating the single cycle growth curve in 24 h. The results obtained show that the restriction of virus infectivity by macrophages is strongly influenced by the multiplicity of infection. This was particularly evident with the adenovirus 17. Moreover, macrophages from patients with melanoma and breast cancer showed an impairment of the intrinsic antiviral activity in comparison with normal subjects. | lld:pubmed |
| pubmed-article:2842553 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2842553 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2842553 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2842553 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2842553 | pubmed:issn | 0736-0118 | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:MastroeniPP | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:BonimeWW | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:IannelloDD | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:GrecoVV | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:ChillemiSS | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:MesitiMM | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:ArenaAA | lld:pubmed |
| pubmed-article:2842553 | pubmed:author | pubmed-author:MerendinoR... | lld:pubmed |
| pubmed-article:2842553 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2842553 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:2842553 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2842553 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2842553 | pubmed:pagination | 191-7 | lld:pubmed |
| pubmed-article:2842553 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:meshHeading | pubmed-meshheading:2842553-... | lld:pubmed |
| pubmed-article:2842553 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2842553 | pubmed:articleTitle | Evaluation of macrophage antiviral activity in patients affected by neoplasia. | lld:pubmed |
| pubmed-article:2842553 | pubmed:affiliation | Institute of Medical Microbiology, University of Messina, Italy. | lld:pubmed |
| pubmed-article:2842553 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2842553 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
